- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Rizatriptan benzoate – November 2009
Rizatriptan benzoate, tablet, 5 mg and 10 mg (base), wafer, 5 mg and 10 mg (base), Maxalt®, November 2009
Last updated
5 March 2010
